{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:51Z","timestamp":1792788111061,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007879","name":"Thure F och Karin Forsbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007879","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Thure F och Karin Forsbergs stiftelse","id":[{"id":"https:\/\/ror.org\/05ndwpr37","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Differentiation of catecholamine-producing tumours from other adrenal tumours remains difficult. Chromogranin A (CgA) is a marker for catecholamine secretion in the body. An assay for quantification of the CgA epitopes vasostatin and catestatin has been validated for use in dogs but not yet evaluated in dogs with catecholamine-producing tumours. The aims were to evaluate the assays foranalysis of plasma concentrations of the CgA epitopes vasostatin and catestatin in dogs with adrenal tumours and to compare concentrations between catecholamine-producing tumours and adrenocortical tumours in dogs that were subjected to adrenalectomy. Twelve dogs with histopathologically confirmed catecholamine-secreting tumours (eleven pheochromocytomas (PCCs), one extra-adrenal sympathetic paraganglioma (PGL)) and twelve with adrenocortical tumours were included in the study. Plasma concentrations of the CgA epitopes vasostatin and catestatin were determined byradioimmunoassay (RIA), before adrenalectomy in 23 out of 24 dogs and after adrenalectomy in six of the dogs with catecholamine-secreting tumours (five PCC, one PGL). Tumour diagnosis was made by histopathology in all cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, median plasma concentration of the CgA epitopevasostatin in dogs with catecholamine-secreting tumours was 0.82 nmol\/L (interquartile range (IQR) 0.52 to 1.60 nmol\/L), which was significantly higher(Wilcoxon rank sum exact test, P= 0.0374) than the vasostatin concentration in adrenocortical tumours (median 0.50; IQR 0.34 to 0.59 nmol\/L). A subsetof dogs (5\/12) with catecholamine-secreting tumours had elevated plasma vasostatin concentrations preoperatively. After successful surgery, thepreoperatively elevated plasma vasostatin concentrations decreased numerically, however without reaching statistical significance. Catestatin concentrationdid not differ between tumour types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated plasma concentration of the CgA epitope vasostatin showed potential as a biomarker for asubset of catecholamine-secreting tumours.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12917-026-05996-6","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:58:07Z","timestamp":1792173487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of plasma chromogranin a epitopes vasostatin and catestatin as biomarkers for catecholamine-producing tumours in dogs"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2418-8557","authenticated-orcid":false,"given":"Josefine","family":"Prabert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5596-9538","authenticated-orcid":false,"given":"Jeanette","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7491-2315","authenticated-orcid":false,"given":"Kumiko","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0099-7974","authenticated-orcid":false,"given":"Kazushi","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7486-0420","authenticated-orcid":false,"given":"Katja","family":"H\u00f6glund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9198-4193","authenticated-orcid":false,"given":"Mats","family":"Stridsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0978-836X","authenticated-orcid":false,"given":"Odd Viking","family":"H\u00f6glund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"1","key":"5996_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","volume":"33","author":"O Mete","year":"2022","unstructured":"Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas. Endocr Pathol. 2022;33(1):90\u2013114. https:\/\/doi.org\/10.1007\/s12022-022-09704-6.","journal-title":"Endocr Pathol"},{"issue":"9486","key":"5996_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"Lenders JW, Eisenhofer G, Mannelli M, Pacak K, Phaeochromocytoma. Lancet. 2005;366(9486):665\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(05)67139-5.","journal-title":"Lancet"},{"issue":"2","key":"5996_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s0195-5616(97)50037-4","volume":"27","author":"ER Maher Jr","year":"1997","unstructured":"Maher ER Jr., McNiel EA. Pheochromocytoma in dogs and cats. Vet Clin North Am Small Anim Pract. 1997;27(2):359\u201380. https:\/\/doi.org\/10.1016\/s0195-5616(97)50037-4.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"5996_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/vco.12291","author":"S Galac","year":"2017","unstructured":"Galac S, Korpershoek E. Pheochromocytomas and paragangliomas in humans and dogs. Vet Comp Oncol. 2017. https:\/\/doi.org\/10.1111\/vco.12291.","journal-title":"Vet Comp Oncol"},{"issue":"2","key":"5996_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ecl.2026.01.007","volume":"55","author":"H Alkaissi","year":"2026","unstructured":"Alkaissi H, Taieb D, Ghayee HK. Pheochromocytomas and Paragangliomas. Endocrinol Metab Clin North Am. 2026;55(2):317\u201344. https:\/\/doi.org\/10.1016\/j.ecl.2026.01.007.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"7","key":"5996_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1507\/endocrj.EJ25-0559","volume":"73","author":"N Kimura","year":"2026","unstructured":"Kimura N. Double faces of pheochromocytoma and paraganglioma-a review of integrated pathologic diagnosis. Endocr J. 2026;73(7):799\u2013810. https:\/\/doi.org\/10.1507\/endocrj.EJ25-0559.","journal-title":"Endocr J"},{"issue":"5","key":"5996_CR7","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1210\/endrev\/bnad011","volume":"44","author":"G Eisenhofer","year":"2023","unstructured":"Eisenhofer G, Pamporaki C, Lenders JWM. Biochemical Assessment of Pheochromocytoma and Paraganglioma. Endocr Rev. 2023;44(5):862\u2013909. https:\/\/doi.org\/10.1210\/endrev\/bnad011.","journal-title":"Endocr Rev"},{"issue":"3","key":"5996_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1939-1676.1994.tb03222.x","volume":"8","author":"SD Gilson","year":"1994","unstructured":"Gilson SD, Withrow SJ, Wheeler SL, Twedt DC. Pheochromocytoma in 50 Dogs. J Vet Intern Med. 1994;8(3):228\u201332. https:\/\/doi.org\/10.1111\/j.1939-1676.1994.tb03222.x.","journal-title":"J Vet Intern Med"},{"issue":"5","key":"5996_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1939-1676.1997.tb00464.x","volume":"11","author":"PY Barthez","year":"1997","unstructured":"Barthez PY, Marks SL, Woo J, Feldman EC, Matteucci M. Pheochromocytoma in dogs: 61 cases (1984\u20131995). Journal of veterinary internal medicine \/. Am Coll Veterinary Intern Med. 1997;11(5):272\u20138. https:\/\/doi.org\/10.1111\/j.1939-1676.1997.tb00464.x.","journal-title":"Am Coll Veterinary Intern Med"},{"key":"5996_CR10","doi-asserted-by":"publisher","first-page":"232470962614511","DOI":"10.1177\/23247096261451176","volume":"14","author":"M Xhikola","year":"2026","unstructured":"Xhikola M, Shirali AS, Sarosi GA, Perdomo-Rodriguez J, Falzarano SM, Cordeiro-Rudnisky F, Ghayee HK. The Biochemical Spectrum of Pheochromocytoma. J Investig Med High Impact Case Rep. 2026;14:23247096261451176. https:\/\/doi.org\/10.1177\/23247096261451176.","journal-title":"J Investig Med High Impact Case Rep"},{"key":"5996_CR11","doi-asserted-by":"publisher","unstructured":"Argenta FF, Slaviero M, de Mello LS, Echenique JVZ, Zorzan AA, Cony FG, Bandinelli MB, de Castro MB, Pavarini SP, Driemeier D, Sonne L. Pathological Aspects and Immunohistochemical Evaluation of Troponin C in the Cardiovascular System of Dogs With Pheochromocytoma. Top Companion Anim Med. 2023;53\u201354100777. https:\/\/doi.org\/10.1016\/j.tcam.2023.100777.","DOI":"10.1016\/j.tcam.2023.100777"},{"key":"5996_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jcpa.2023.04.006","volume":"204","author":"J Poldy","year":"2023","unstructured":"Poldy J, Gelendi S, Starybrat D, Del-Pozo J. Phaeochromocytoma associated with cardiomyopathy and leukocytoclastic vasculitis in a dog. J Comp Pathol. 2023;204:30\u20134. https:\/\/doi.org\/10.1016\/j.jcpa.2023.04.006.","journal-title":"J Comp Pathol"},{"key":"5996_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-026-00798-9","author":"E Kakargia","year":"2026","unstructured":"Kakargia E, Tsentidis C, Fountas A, Mantzouranis E, Kanti G, Markou A, Papanastasiou L. Prognostic factors for cardiovascular complications induced by catecholamines in pheochromocytomas and paragangliomas: a systematic review and meta-analysis. Horm (Athens). 2026. https:\/\/doi.org\/10.1007\/s42000-026-00798-9.","journal-title":"Horm (Athens)"},{"issue":"5","key":"5996_CR14","doi-asserted-by":"publisher","first-page":"e70220","DOI":"10.1111\/jvim.70220","volume":"39","author":"MME van den Steele","year":"2025","unstructured":"van den Steele MME, Galac S, Dordio AM, Threlfall A, Gomes C, Paul A, Nolff M, Sieber-Ruckstuhl N, Benchekroun G, et al. A Multicenter, Retrospective Analysis of Long-Term Survival in 255 Dogs With Pheochromocytoma Treated With Alpha-Adrenoreceptor Antagonists or Surgery (2010\u20132021). J Vet Intern Med. 2025;39(5):e70220. https:\/\/doi.org\/10.1111\/jvim.70220.","journal-title":"J Vet Intern Med"},{"issue":"6","key":"5996_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1740-8261.2000.tb01877.x","volume":"41","author":"DS Rosenstein","year":"2000","unstructured":"Rosenstein DS. Diagnostic imaging in canine pheochromocytoma. Vet Radiol Ultrasound. 2000;41(6):499\u2013506. https:\/\/doi.org\/10.1111\/j.1740-8261.2000.tb01877.x.","journal-title":"Vet Radiol Ultrasound"},{"issue":"10","key":"5996_CR16","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2460\/javma.244.10.1181","volume":"244","author":"AK Cook","year":"2014","unstructured":"Cook AK, Spaulding KA, Edwards JF. Clinical findings in dogs with incidental adrenal gland lesions determined by ultrasonography: 151 cases (2007\u20132010). J Am Vet Med Assoc. 2014;244(10):1181\u20135. https:\/\/doi.org\/10.2460\/javma.244.10.1181.","journal-title":"J Am Vet Med Assoc"},{"issue":"10","key":"5996_CR17","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2460\/javma.249.10.1165","volume":"249","author":"JI Baum","year":"2016","unstructured":"Baum JI, Boston SE, Case JB. Prevalence of adrenal gland masses as incidental findings during abdominal computed tomography in dogs: 270 cases (2013\u20132014). J Am Vet Med Assoc. 2016;249(10):1165\u20139. https:\/\/doi.org\/10.2460\/javma.249.10.1165.","journal-title":"J Am Vet Med Assoc"},{"issue":"2","key":"5996_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/cen.70167","volume":"105","author":"O Uzun","year":"2026","unstructured":"Uzun O, Icin BB, Cakir B, Tural Balsak BO, Nasiroglu Imga N, Soltanova L, Kadioglu P, Sahin Kimyon O, Ciftci S, Kandemir Alibakan O, et al. Differences in Clinical Outcomes Between Patients With Incidentally Detected and Clinically Detected Pheochromocytomas and Paragangliomas: A Retrospective Multicenter Study. Clin Endocrinol (Oxf). 2026;105(2):185\u201396. https:\/\/doi.org\/10.1111\/cen.70167.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5996_CR19","doi-asserted-by":"publisher","first-page":"1023220","DOI":"10.3389\/fendo.2022.1023220","volume":"13","author":"A Qdaisat","year":"2022","unstructured":"Qdaisat A, Bedrose S, Ezzeldin O, Moawad AW, Yeung SJ, Elsayes KM, Habra MA. The prevalence and spectrum of reported incidental adrenal abnormalities in abdominal computed tomography of cancer patients: The experience of a comprehensive cancer center. Front Endocrinol (Lausanne). 2022;13:1023220. https:\/\/doi.org\/10.3389\/fendo.2022.1023220.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"5996_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/vru.12209","volume":"56","author":"T Gregori","year":"2015","unstructured":"Gregori T, Mantis P, Benigni L, Priestnall SL, Lamb CR. Comparison of Computed Tomographic and Pathologic Findings in 17 Dogs with Primary Adrenal Neoplasia. Vet Radio Ultrasound. 2015;56(2):153\u20139. https:\/\/doi.org\/10.1111\/vru.12209.","journal-title":"Vet Radio Ultrasound"},{"issue":"4","key":"5996_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/vsu.12462","volume":"45","author":"O Yoshida","year":"2016","unstructured":"Yoshida O, Kutara K, Seki M, Ishigaki K, Teshima K, Ishikawa C, Iida G, Edamura K, Kagawa Y, Asano K. Preoperative Differential Diagnosis of Canine Adrenal Tumors Using Triple-Phase Helical Computed Tomography. Vet Surg. 2016;45(4):427\u201335. https:\/\/doi.org\/10.1111\/vsu.12462.","journal-title":"Vet Surg"},{"issue":"3","key":"5996_CR22","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/vms3.1110","volume":"9","author":"R Takeuchi","year":"2023","unstructured":"Takeuchi R, Ishigaki K, Yoshida O, Sakurai N, Terai K, Heishima T, Asano K. Preemptively planned en bloc resection of an extensive right adrenal pheochromocytoma involving the right hepatic division, caval thrombus and segmental caudal vena cava in a dog with Budd\u2013Chiari-like syndrome. Veterinary Med Sci. 2023;9(3):1078\u201386. https:\/\/doi.org\/10.1002\/vms3.1110.","journal-title":"Veterinary Med Sci"},{"issue":"S1","key":"5996_CR23","doi-asserted-by":"publisher","first-page":"O70","DOI":"10.1111\/vsu.12552","volume":"45","author":"KA Pitt","year":"2016","unstructured":"Pitt KA, Mayhew PD, Steffey MA, Culp WTN, Fuller MC, Della Maggiore A, Nelson RW. Laparoscopic Adrenalectomy for Removal of Unilateral Noninvasive Pheochromocytomas in 10 Dogs. Vet Surg. 2016;45(S1):O70\u20136. https:\/\/doi.org\/10.1111\/vsu.12552.","journal-title":"Vet Surg"},{"key":"5996_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-026-05640-3","author":"SK Tan","year":"2026","unstructured":"Tan SK, Hosgood GL, Curnow M. Unilateral phaeochromocytoma in a dog with pre-existing, long-standing primary hypoadrenocorticism: a case report. BMC Vet Res. 2026. https:\/\/doi.org\/10.1186\/s12917-026-05640-3.","journal-title":"BMC Vet Res"},{"issue":"3","key":"5996_CR25","doi-asserted-by":"publisher","first-page":"e70021","DOI":"10.1111\/jvim.70021","volume":"39","author":"HJ Piegols","year":"2025","unstructured":"Piegols HJ, Williams RW, Pathak N, Selmic LE, Tremolada G, Sakacs R, Millward L, Lapsley J. Cytologic Evaluation as a Diagnostic Tool to Differentiate Adrenocortical Tumors and Pheochromocytomas. J Vet Intern Med. 2025;39(3):e70021. https:\/\/doi.org\/10.1111\/jvim.70021.","journal-title":"J Vet Intern Med"},{"issue":"2","key":"5996_CR26","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/jvim.15743","volume":"34","author":"P Pey","year":"2020","unstructured":"Pey P, Diana A, Rossi F, Mortier J, Kafka U, Veraa S, Groth A, MacLellan M, Marin C, Fracassi F. Safety of percutaneous ultrasound-guided fine-needle aspiration of adrenal lesions in dogs: Perception of the procedure by radiologists and presentation of 50 cases. J Vet Intern Med. 2020;34(2):626\u201335. https:\/\/doi.org\/10.1111\/jvim.15743.","journal-title":"J Vet Intern Med"},{"issue":"4","key":"5996_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/vcp.12093","volume":"42","author":"BA Green","year":"2013","unstructured":"Green BA, Frank EL. Comparison of plasma free metanephrines between healthy dogs and 3 dogs with pheochromocytoma. Vet Clin Pathol. 2013;42(4):499\u2013503. https:\/\/doi.org\/10.1111\/vcp.12093.","journal-title":"Vet Clin Pathol"},{"issue":"1","key":"5996_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/jvim.12009","volume":"27","author":"R Gostelow","year":"2013","unstructured":"Gostelow R, Bridger N, Syme HM. Plasma-Free Metanephrine and Free Normetanephrine Measurement for the Diagnosis of Pheochromocytoma in Dogs. J Vet Intern Med. 2013;27(1):83\u201390. https:\/\/doi.org\/10.1111\/jvim.12009.","journal-title":"J Vet Intern Med"},{"issue":"2","key":"5996_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/jvim.12569","volume":"29","author":"E Salesov","year":"2015","unstructured":"Salesov E, Boretti FS, Sieber-Ruckstuhl NS, Rentsch KM, Riond B, Hofmann-Lehmann R, Kircher PR, Grouzmann E, Reusch CE. Urinary and plasma catecholamines and metanephrines in dogs with pheochromocytoma, hypercortisolism, nonadrenal disease and in healthy dogs. J Vet Intern Med. 2015;29(2):597\u2013602. https:\/\/doi.org\/10.1111\/jvim.12569.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"5996_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2460\/javma.24.06.0409","volume":"263","author":"C Waldron","year":"2025","unstructured":"Waldron C, Thamm DH, Watson-Skaggs M, Vinayak A. High specificity and sensitivity of spot urine normetanephrine-to-creatinine ratios in the diagnosis of canine pheochromocytoma. J Am Vet Med Assoc. 2025;263(3):359\u201367. https:\/\/doi.org\/10.2460\/javma.24.06.0409.","journal-title":"J Am Vet Med Assoc"},{"issue":"6","key":"5996_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/vr.b4760","volume":"166","author":"PH Kook","year":"2010","unstructured":"Kook PH, Grest P, Quante S, Boretti FS, Reusch CE. Urinary catecholamine and metadrenaline to creatinine ratios in dogs with a phaeochromocytoma. Vet Rec. 2010;166(6):169\u201374. https:\/\/doi.org\/10.1136\/vr.b4760.","journal-title":"Vet Rec"},{"issue":"5","key":"5996_CR32","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/j.1939-1676.2010.0578.x","volume":"24","author":"S Quante","year":"2010","unstructured":"Quante S, Boretti FS, Kook PH, Mueller C, Schellenberg S, Zini E, Sieber-Ruckstuhl N, Reusch CE. Urinary catecholamine and metanephrine to creatinine ratios in dogs with hyperadrenocorticism or pheochromocytoma, and in healthy dogs. J Vet Intern Med. 2010;24(5):1093\u20137. https:\/\/doi.org\/10.1111\/j.1939-1676.2010.0578.x.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"5996_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1892\/0891-6640(2007)21[388:ucamtc]2.0.co;2","volume":"21","author":"PH Kook","year":"2007","unstructured":"Kook PH, Boretti FS, Hersberger M, Glaus TM, Reusch CE. Urinary catecholamine and metanephrine to creatinine ratios in healthy dogs at home and in a hospital environment and in 2 dogs with pheochromocytoma. J Vet Intern Med. 2007;21(3):388\u201393. https:\/\/doi.org\/10.1892\/0891-6640(2007)21[388:ucamtc]2.0.co;2.","journal-title":"J Vet Intern Med"},{"issue":"7","key":"5996_CR34","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/0024-3205(87)90176-7","volume":"41","author":"P Hjemdahl","year":"1987","unstructured":"Hjemdahl P. Physiological aspects on catecholamine sampling. Life Sci. 1987;41(7):841\u20134. https:\/\/doi.org\/10.1016\/0024-3205(87)90176-7.","journal-title":"Life Sci"},{"issue":"6","key":"5996_CR35","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/j.1939-1676.2012.00999.x","volume":"26","author":"K H\u00f6glund","year":"2012","unstructured":"H\u00f6glund K, Han\u00e5s S, Carnabuci C, Ljungvall I, Tidholm A, H\u00e4ggstr\u00f6m J. Blood pressure, heart rate and urinary catecholamines in healthy dogs subjected to different clinical settings. J Vet Intern Med. 2012;26(6):1300\u20138. https:\/\/doi.org\/10.1111\/j.1939-1676.2012.00999.x.","journal-title":"J Vet Intern Med"},{"issue":"1","key":"5996_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/jvim.12027","volume":"27","author":"C Br\u00f6mel","year":"2013","unstructured":"Br\u00f6mel C, Nelson RW, Feldman EC, Munro CJ, Kass PH, Vico AE, Labelle P, Conley AJ. Serum Inhibin Concentration in Dogs with Adrenal Gland Disease and in Healthy Dogs. J Vet Intern Med. 2013;27(1):76\u201382. https:\/\/doi.org\/10.1111\/jvim.12027.","journal-title":"J Vet Intern Med"},{"issue":"6","key":"5996_CR37","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.5455\/OVJ.2024.v14.i6.17","volume":"14","author":"M Gavet","year":"2024","unstructured":"Gavet M, Junot S. Anesthetic management of a dog undergoing unilateral adrenalectomy for phaeochromocytoma excision using a partial intravenous anesthetic protocol. Open Vet J. 2024;14(6):1483\u201390. https:\/\/doi.org\/10.5455\/OVJ.2024.v14.i6.17.","journal-title":"Open Vet J"},{"issue":"4","key":"5996_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.21037\/gs-2025-325","volume":"15","author":"B Sensi","year":"2026","unstructured":"Sensi B, Wang K, Kopczynska M, Kumar K, Chukwamaife U, Carroll C, Doran H. Severe intraoperative hypertensive crisis during surgery for phaeochromocytoma\/paraganglioma: analysis of pre-operative risk factors. Gland Surg. 2026;15(4):97. https:\/\/doi.org\/10.21037\/gs-2025-325.","journal-title":"Gland Surg"},{"issue":"4","key":"5996_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12022-024-09830-3","volume":"35","author":"CJM de Bresser","year":"2024","unstructured":"de Bresser CJM, de Krijger RR. The Molecular Classification of Pheochromocytomas and Paragangliomas: Discovering the Genomic and Immune Landscape of Metastatic Disease. Endocr Pathol. 2024;35(4):279\u201392. https:\/\/doi.org\/10.1007\/s12022-024-09830-3.","journal-title":"Endocr Pathol"},{"key":"5996_CR40","doi-asserted-by":"publisher","unstructured":"Megha Murali GV, Nayal B, Nayak D, Monappa V, Garg S, Priya PS, Menon G, Nayak R, Pujary K, Balakrishnan R, Pillai S. Clinicopathological profile of paragangliomas: A 5-Year retrospective analysis from a single tertiary Centre. Diagn Pathol. 2026;21(1). https:\/\/doi.org\/10.1186\/s13000-026-01771-1.","DOI":"10.1186\/s13000-026-01771-1"},{"issue":"1","key":"5996_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/his.70045","volume":"88","author":"LA Erickson","year":"2026","unstructured":"Erickson LA, Gupta S, Whaley RD. Pathology of adrenal tumours: recent advances. Histopathology. 2026;88(1):301\u201316. https:\/\/doi.org\/10.1111\/his.70045.","journal-title":"Histopathology"},{"issue":"12","key":"5996_CR42","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJMra021405","volume":"348","author":"L Taupenot","year":"2003","unstructured":"Taupenot L, Harper KL, O\u2019Connor DT. The chromogranin-secretogranin family. N Engl J Med. 2003;348(12):1134\u201349. https:\/\/doi.org\/10.1056\/NEJMra021405.","journal-title":"N Engl J Med"},{"issue":"12","key":"5996_CR43","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1056\/NEJM198409203111204","volume":"311","author":"DT O\u2019Connor","year":"1984","unstructured":"O\u2019Connor DT, Bernstein KN. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N Engl J Med. 1984;311(12):764\u201370. https:\/\/doi.org\/10.1056\/NEJM198409203111204.","journal-title":"N Engl J Med"},{"issue":"381","key":"5996_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-016-2193-1","volume":"9","author":"T Srithunyarat","year":"2016","unstructured":"Srithunyarat T, H\u00f6glund OV, Hagman R, Olsson U, Stridsberg M, Lagerstedt AS, Pettersson A. Catestatin, vasostatin, cortisol, temperature, heart rate, respiratory rate, scores of the short form of the Glasgow composite measure pain scale and visual analog scale for stress and pain behavior in dogs before and after ovariohysterectomy. BMC Res Notes. 2016;9(381):1\u20139. https:\/\/doi.org\/10.1186\/s13104-016-2193-1.","journal-title":"BMC Res Notes"},{"issue":"2 Pt 1","key":"5996_CR45","doi-asserted-by":"publisher","first-page":"E243","DOI":"10.1152\/ajpendo.1991.260.2.E243","volume":"260","author":"PE Cryer","year":"1991","unstructured":"Cryer PE, Wortsman J, Shah SD, Nowak RM, Deftos LJ. Plasma chromogranin A as a marker of sympathochromaffin activity in humans. Am J Physiol. 1991;260(2 Pt 1):E243\u2013246. https:\/\/doi.org\/10.1152\/ajpendo.1991.260.2.E243.","journal-title":"Am J Physiol"},{"issue":"7","key":"5996_CR46","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0024-3205(92)90029-O","volume":"51","author":"JE Dimsdale","year":"1992","unstructured":"Dimsdale JE, O\u2019Connor DT, Ziegler M, Mills P. Chromogranin A correlates with norepinephrine release rate. Life Sci. 1992;51(7):519\u201325. https:\/\/doi.org\/10.1016\/0024-3205(92)90029-O.","journal-title":"Life Sci"},{"issue":"3","key":"5996_CR47","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1210\/jcem-72-3-616","volume":"72","author":"MA Takiyyuddin","year":"1991","unstructured":"Takiyyuddin MA, Baron AD, Cervenka JH, Barbosa JA, Neumann HP, Parmer RJ, Sullivan PA, O\u2019Connor DT. Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies. J Clin Endocrinol Metab. 1991;72(3):616\u201322. https:\/\/doi.org\/10.1210\/jcem-72-3-616.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"5996_CR48","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1530\/EC-14-0027","volume":"3","author":"MA D\u2019Amico","year":"2014","unstructured":"D\u2019Amico MA, Ghinassi B, Izzicupo P, Manzoli L, Di Baldassarre A. Biological function and clinical relevance of chromogranin A and derived peptides. Endocr Connect. 2014;3(2):R45\u201354. https:\/\/doi.org\/10.1530\/EC-14-0027.","journal-title":"Endocr Connect"},{"issue":"15","key":"5996_CR49","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1200\/JCO.2006.10.1535","volume":"25","author":"D Campana","year":"2007","unstructured":"Campana D, Nori F, Piscitelli L, Morselli-Labate AM, Pezzilli R, Corinaldesi R, Tomassetti P. Chromogranin A: is it a useful marker of neuroendocrine tumors? J Clin Oncol. 2007;25(15):1967\u201373. https:\/\/doi.org\/10.1200\/JCO.2006.10.1535.","journal-title":"J Clin Oncol"},{"issue":"1","key":"5996_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5662\/wjm.v7.i1.9","volume":"7","author":"S Gkolfinopoulos","year":"2017","unstructured":"Gkolfinopoulos S, Tsapakidis K, Papadimitriou K, Papamichael D, Kountourakis P. Chromogranin A as a valid marker in oncology: Clinical application or false hopes? World J Methodol. 2017;7(1):9\u201315. https:\/\/doi.org\/10.5662\/wjm.v7.i1.9.","journal-title":"World J Methodol"},{"issue":"1","key":"5996_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/172460089801300102","volume":"13","author":"L Ferrari","year":"1998","unstructured":"Ferrari L, Seregni E, Martinetti A, Van Graafeiland B, Nerini-Molteni S, Botti C, Artale S, Cresta S, Bombardieri E. Chromogranin A measurement in neuroendocrine tumors. Int J Biol Markers. 1998;13(1):3\u20139. https:\/\/doi.org\/10.1177\/172460089801300102.","journal-title":"Int J Biol Markers"},{"issue":"1","key":"5996_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/aoms.2016.57577","volume":"12","author":"P Gut","year":"2016","unstructured":"Gut P, Czarnywojtek A, Fischbach J, Baczyk M, Ziemnicka K, Wrotkowska E, Gryczynska M, Ruchala M. Chromogranin A - unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls. Arch Med Sci. 2016;12(1):1\u20139. https:\/\/doi.org\/10.5114\/aoms.2016.57577.","journal-title":"Arch Med Sci"},{"issue":"4","key":"5996_CR53","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ecl.2010.09.001","volume":"39","author":"JE Ardill","year":"2010","unstructured":"Ardill JE, O\u2019Dorisio TM. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators. Endocrinol Metab Clin North Am. 2010;39(4):777\u201390. https:\/\/doi.org\/10.1016\/j.ecl.2010.09.001.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"5996_CR54","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1677\/joe.0.1650703","volume":"165","author":"M Stridsberg","year":"2000","unstructured":"Stridsberg M, Angeletti RH, Helle KB. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods. J Endocrinol. 2000;165(3):703\u201314. https:\/\/doi.org\/10.1677\/joe.0.1650703.","journal-title":"J Endocrinol"},{"issue":"336","key":"5996_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-7-336","volume":"7","author":"M Stridsberg","year":"2014","unstructured":"Stridsberg M, Pettersson A, Hagman R, Westin C, H\u00f6glund O. Chromogranins can be measured in samples from cats and dogs. BMC Res Notes. 2014;7(336):1\u20134. https:\/\/doi.org\/10.1186\/1756-0500-7-336.","journal-title":"BMC Res Notes"},{"issue":"10","key":"5996_CR56","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.2460\/ajvr.2005.66.1830","volume":"66","author":"H Akiyoshi","year":"2005","unstructured":"Akiyoshi H, Aoki M, Shimada T, Noda K, Kumagai D, Saleh N, Sugii S, Ohashi F. Measurement of plasma chromogranin A concentrations for assessment of stress responses in dogs with insulin-induced hypoglycemia. Am J Vet Res. 2005;66(10):1830\u20135. https:\/\/doi.org\/10.2460\/ajvr.2005.66.1830.","journal-title":"Am J Vet Res"},{"issue":"4","key":"5996_CR57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4142\/jvs.2008.9.4.421","volume":"9","author":"K Kanai","year":"2008","unstructured":"Kanai K, Hino M, Hori Y, Nakao R, Hoshi F, Itoh N, Higuchi S. Circadian variations in salivary chromogranin a concentrations during a 24-hour period in dogs. J Vet Sci. 2008;9(4):421\u20133. https:\/\/doi.org\/10.4142\/jvs.2008.9.4.421.","journal-title":"J Vet Sci"},{"key":"5996_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2050312115576432","volume":"3","author":"OV H\u00f6glund","year":"2015","unstructured":"H\u00f6glund OV, Hagman R, Stridsberg M. Chromogranin A and cortisol at intraoperative repeated noxious stimuli: Surgical stress in a dog model. SAGE Open Med. 2015;3:1\u20136. https:\/\/doi.org\/10.1177\/2050312115576432.","journal-title":"SAGE Open Med"},{"key":"5996_CR59","unstructured":"H\u00f6glund K, Stridsberg M, H\u00f6glund OV, Tidholm A, H\u00e4ggstr\u00f6m J, Ljungvall I. Usefulness of plasma concentration of chromogranin A as an indicator of sympathetic tone in dogs with myxomatous mitral valve disease. In Book Usefulness of plasma concentration of chromogranin A as an indicator of sympathetic tone in dogs with myxomatous mitral valve disease (Editor ed.^eds.). City; 2014:1354."},{"key":"5996_CR60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12917-015-0328-6","volume":"11","author":"S Jitpean","year":"2015","unstructured":"Jitpean S, Stridsberg M, Pettersson A, H\u00f6glund OV, Holst BS, Hagman R. Decreased plasma Chromogranin A361-372 (Catestatin) but not Chromogranin A17-38 (Vasostatin) in female dogs with bacterial uterine infection (pyometra). BMC Vet Res. 2015;11:14. https:\/\/doi.org\/10.1186\/s12917-015-0328-6.","journal-title":"BMC Vet Res"},{"issue":"6","key":"5996_CR61","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2460\/ajvr.1997.58.06.615","volume":"58","author":"NC Myers 3rd","year":"1997","unstructured":"Myers NC 3rd, Andrews GA, Chard-Bergstrom C. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats. Am J Vet Res. 1997;58(6):615\u201320. https:\/\/doi.org\/10.2460\/ajvr.1997.58.06.615.","journal-title":"Am J Vet Res"},{"issue":"1","key":"5996_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13028-016-0274-8","volume":"59","author":"T Srithunyarat","year":"2017","unstructured":"Srithunyarat T, Hagman R, H\u00f6glund OV, Olsson U, Stridsberg M, Jitpean S, Lagerstedt AS, Pettersson A. Catestatin and vasostatin concentrations in healthy dogs. Acta Vet Scand. 2017;59(1):1\u20138. https:\/\/doi.org\/10.1186\/s13028-016-0274-8.","journal-title":"Acta Vet Scand"},{"issue":"129","key":"5996_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-017-2450-y","volume":"10","author":"T Srithunyarat","year":"2017","unstructured":"Srithunyarat T, Hagman R, H\u00f6glund OV, Stridsberg M, Olsson U, Hanson J, Nonthakotr C, Lagerstedt AS, Pettersson A. Catestatin, vasostatin, cortisol, and pain assessments in dogs suffering from traumatic bone fractures. BMC Res Notes. 2017;10(129):1\u201310. https:\/\/doi.org\/10.1186\/s13104-017-2450-y.","journal-title":"BMC Res Notes"},{"issue":"1","key":"5996_CR64","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13028-020-00541-3","volume":"62","author":"K H\u00f6glund","year":"2020","unstructured":"H\u00f6glund K, H\u00e4ggstr\u00f6m J, H\u00f6glund OV, Stridsberg M, Tidholm A, Ljungvall I. The chromogranin A-derived peptides catestatin and vasostatin in dogs with myxomatous mitral valve disease. Acta Vet Scand. 2020;62(1):43. https:\/\/doi.org\/10.1186\/s13028-020-00541-3.","journal-title":"Acta Vet Scand"},{"key":"5996_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcpa.2022.04.002","volume":"195","author":"SP Hu","year":"2022","unstructured":"Hu SP, Zhang Z, Xiao F, Huang JN, Jiang Y, Mao DS, Wang JF, He XJ. Paraganglioma of the Urinary Bladder in a Dog. J Comp Pathol. 2022;195:1\u20136. https:\/\/doi.org\/10.1016\/j.jcpa.2022.04.002.","journal-title":"J Comp Pathol"},{"issue":"6","key":"5996_CR66","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1055\/s-0038-1677406","volume":"46","author":"MC Fischer","year":"2018","unstructured":"Fischer MC, Taeymans ON, Monti P, Scurrell EJ, Eddicks L, Matiasek K, Busse C. Orbital paraganglioma in a dog. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2018;46(6):410\u20135. https:\/\/doi.org\/10.1055\/s-0038-1677406.","journal-title":"Tierarztl Prax Ausg K Kleintiere Heimtiere"},{"issue":"3","key":"5996_CR67","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.regpep.2003.10.023","volume":"117","author":"M Stridsberg","year":"2004","unstructured":"Stridsberg M, Eriksson B, \u00d6berg K, Janson ET. A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A. Regul Pept. 2004;117(3):219\u201327. https:\/\/doi.org\/10.1016\/j.regpep.2003.10.023.","journal-title":"Regul Pept"},{"issue":"2","key":"5996_CR68","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3109\/1354750X.2012.654511","volume":"17","author":"V Marotta","year":"2012","unstructured":"Marotta V, Nuzzo V, Ferrara T, Zuccoli A, Masone M, Nocerino L, Del Prete M, Marciello F, Ramundo V, Lombardi G, et al. Limitations of Chromogranin A in clinical practice. Biomarkers. 2012;17(2):186\u201391. https:\/\/doi.org\/10.3109\/1354750X.2012.654511.","journal-title":"Biomarkers"},{"issue":"4 Part 1","key":"5996_CR69","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1161\/01.cir.14.4.622","volume":"14","author":"WF Kvale","year":"1956","unstructured":"Kvale WF, Manger WM, Priestley JT, Roth GM, Pheochromocytoma. Circulation. 1956;14(4 Part 1):622\u201330. https:\/\/doi.org\/10.1161\/01.cir.14.4.622.","journal-title":"Circulation"},{"issue":"5","key":"5996_CR70","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1365-2265.2004.02030.x","volume":"60","author":"D Nehar","year":"2004","unstructured":"Nehar D, Lombard-Bohas C, Olivieri S, Claustrat B, Chayvialle JA, Penes MC, Sassolas G, Borson-Chazot F. Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours. Clin Endocrinol (Oxf). 2004;60(5):644\u201352. https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02030.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"5996_CR71","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s12020-021-02964-y","volume":"76","author":"Y Guo","year":"2022","unstructured":"Guo Y, Li H, Xie D, You L, Yan L, Li Y, Zhang S. Hemorrhage in pheochromocytoma surgery: evaluation of preoperative risk factors. Endocrine. 2022;76(2):426\u201333. https:\/\/doi.org\/10.1007\/s12020-021-02964-y.","journal-title":"Endocrine"},{"key":"5996_CR72","doi-asserted-by":"publisher","unstructured":"Parente A, Kamarajah SK, Thompson JP, Crook C, Aspinall S, Melvin R, Stechman MJ, Perry H, Balasubramanian SP, Pannu A, et al. Risk factors for postoperative complications after adrenalectomy for phaeochromocytoma: multicentre cohort study. BJS Open. 2023;7(5). https:\/\/doi.org\/10.1093\/bjsopen\/zrad090.","DOI":"10.1093\/bjsopen\/zrad090"},{"issue":"6","key":"5996_CR73","doi-asserted-by":"publisher","first-page":"101958","DOI":"10.1016\/j.beem.2024.101958","volume":"38","author":"O Mete","year":"2024","unstructured":"Mete O, Juhlin CC. Recent progress in the pathologic classification of pheochromocytomas and paragangliomas. Best Pract Res Clin Endocrinol Metab. 2024;38(6):101958. https:\/\/doi.org\/10.1016\/j.beem.2024.101958.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"5996_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-026-00792-1","author":"Y Zhou","year":"2026","unstructured":"Zhou Y, Cui Y, Li T, Tong A. Multi-omics insights into metastatic pheochromocytomas and paragangliomas: Mechanisms, signatures, and prediction models. Horm (Athens). 2026. https:\/\/doi.org\/10.1007\/s42000-026-00792-1.","journal-title":"Horm (Athens)"},{"issue":"2","key":"5996_CR75","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s12020-010-9422-5","volume":"39","author":"A Szalat","year":"2011","unstructured":"Szalat A, Fraenkel M, Doviner V, Salmon A, Gross DJ. Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center. Endocrine. 2011;39(2):160\u20136. https:\/\/doi.org\/10.1007\/s12020-010-9422-5.","journal-title":"Endocrine"},{"issue":"5","key":"5996_CR76","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1369\/00221554221091000","volume":"70","author":"H Gomi","year":"2022","unstructured":"Gomi H, Nagumo T, Asano K, Konosu M, Yasui T, Torii S, Hosaka M. Differential Expression of Secretogranins II and III in Canine Adrenal Chromaffin Cells and Pheochromocytomas. J Histochem Cytochemistry. 2022;70(5):335\u201356. https:\/\/doi.org\/10.1369\/00221554221091000.","journal-title":"J Histochem Cytochemistry"},{"issue":"1","key":"5996_CR77","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.regpep.2010.02.011","volume":"165","author":"GM Portela-Gomes","year":"2010","unstructured":"Portela-Gomes GM, Grimelius L, Wilander E, Stridsberg M. Granins and granin-related peptides in neuroendocrine tumours. Regul Pept. 2010;165(1):12\u201320. https:\/\/doi.org\/10.1016\/j.regpep.2010.02.011.","journal-title":"Regul Pept"},{"key":"5996_CR78","doi-asserted-by":"publisher","first-page":"111258","DOI":"10.1016\/j.mce.2021.111258","volume":"528","author":"N Bechmann","year":"2021","unstructured":"Bechmann N, Berger I, Bornstein SR, Steenblock C. Adrenal medulla development and medullary-cortical interactions. Mol Cell Endocrinol. 2021;528:111258. https:\/\/doi.org\/10.1016\/j.mce.2021.111258.","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"5996_CR79","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1007\/s00595-012-0458-4","volume":"43","author":"N Michalopoulos","year":"2013","unstructured":"Michalopoulos N, Pazaitou-Panayiotou K, Boudina M, Papavramidis T, Karayannopoulou G, Papavramidis S. Mixed corticomedullary adrenal carcinoma. Surg Today. 2013;43(11):1232\u20139. https:\/\/doi.org\/10.1007\/s00595-012-0458-4.","journal-title":"Surg Today"},{"issue":"3","key":"5996_CR80","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.aed.2025.12.018","volume":"13","author":"GA Stamatiades","year":"2026","unstructured":"Stamatiades GA, Bikas A, Shah HJ, Wong KS, Vaidya A, Nehs MA, Basaria SS. Ectopic Cushing Syndrome due to an Adrenocorticotropic Hormone-Producing Pheochromocytoma. AACE Endocrinol Diabetes. 2026;13(3):492\u20136. https:\/\/doi.org\/10.1016\/j.aed.2025.12.018.","journal-title":"AACE Endocrinol Diabetes"},{"key":"5996_CR81","doi-asserted-by":"publisher","unstructured":"Kim D, Park SG, Moon J, O IS, Kim MS. Metanephrine-secreting adrenocortical carcinoma in a dog with clinical and biochemical features suggestive of pheochromocytoma. J Vet Intern Med. 2026;40(3). https:\/\/doi.org\/10.1093\/jvimsj\/aalag110.","DOI":"10.1093\/jvimsj\/aalag110"},{"issue":"1","key":"5996_CR82","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00428-025-04379-w","volume":"488","author":"O Mete","year":"2026","unstructured":"Mete O, Juhlin CC. The evolving roles of pathologists in paragangliomas and pheochromocytomas. Virchows Arch. 2026;488(1):173\u201391. https:\/\/doi.org\/10.1007\/s00428-025-04379-w.","journal-title":"Virchows Arch"},{"issue":"4","key":"5996_CR83","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/eci.12245","volume":"44","author":"S Zuber","year":"2014","unstructured":"Zuber S, Wesley R, Prodanov T, Eisenhofer G, Pacak K, Kantorovich V. Clinical utility of chromogranin A in SDHx-related paragangliomas. Eur J Clin Invest. 2014;44(4):365\u201371. https:\/\/doi.org\/10.1111\/eci.12245.","journal-title":"Eur J Clin Invest"},{"key":"5996_CR84","doi-asserted-by":"publisher","unstructured":"Korpershoek E, Dieduksman D, Grinwis GCM, Day MJ, Reusch CE, Hilbe M, Fracassi F, Krol NMG, Uitterlinden AG, de Klein A, et al. Molecular Alterations in Dog Pheochromocytomas and Paragangliomas. Cancers (Basel). 2019;11(5). https:\/\/doi.org\/10.3390\/cancers11050607.","DOI":"10.3390\/cancers11050607"},{"issue":"5","key":"5996_CR85","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1111\/jvim.17148","volume":"38","author":"MF n den Berg","year":"2024","unstructured":"n den Berg MF, Bechmann N, Kooistra HS, van Wolferen ME, Timmermans-Sprang EPM, Peitzsch M, Galac S. Metabolomic profiling of pheochromocytomas in dogs: Catecholamine phenotype and tricarboxylic acid cycle metabolites. J Vet Intern Med. 2024;38(5):2415\u201324. https:\/\/doi.org\/10.1111\/jvim.17148.","journal-title":"J Vet Intern Med"},{"issue":"3","key":"5996_CR86","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/0970-9185.161665","volume":"31","author":"H Ramakrishna","year":"2015","unstructured":"Ramakrishna H. Pheochromocytoma resection: Current concepts in anesthetic management. J Anaesthesiol Clin Pharmacol. 2015;31(3):317\u201323. https:\/\/doi.org\/10.4103\/0970-9185.161665.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"5","key":"5996_CR87","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.vaa.2025.03.005","volume":"52","author":"ML Machado","year":"2025","unstructured":"Machado ML, Pypendop BH, Soares JH. Management of refractory hypotension during adrenalectomy in a dog treated with phenoxybenzamine. Vet Anaesth Analg. 2025;52(5):682\u20136. https:\/\/doi.org\/10.1016\/j.vaa.2025.03.005.","journal-title":"Vet Anaesth Analg"},{"key":"5996_CR88","doi-asserted-by":"publisher","unstructured":"Memon LC, Lila SS, Karlekar AR, Phadte M, Sarathi A, Barnabas V, Bijani R, Rege SP, Takalkar S. Preoperative first-line amlodipine in phaeochromocytoma\/paraganglioma: perioperative haemodynamic instability and its predictors. Endocr Connect. 2026;15(4). https:\/\/doi.org\/10.1530\/EC-25-0921.","DOI":"10.1530\/EC-25-0921"},{"key":"5996_CR89","doi-asserted-by":"publisher","DOI":"10.1111\/vsu.12710","volume-title":"Serum Chromogranin A (vasostatin) as a biomarker for catecholamine-producing tumors in dogs","author":"OV H\u00f6glund","year":"2017","unstructured":"H\u00f6glund OV, Yoshida O, Asano K, Ishigaki K, Stridsberg M, Hanson J. Serum Chromogranin A (vasostatin) as a biomarker for catecholamine-producing tumors in dogs. USA: ACVS. Indianapolis; 2017. https:\/\/doi.org\/10.1111\/vsu.12710."},{"key":"5996_CR90","doi-asserted-by":"publisher","unstructured":"H\u00f6glund OV, Yoshida O, Asano K, Ishigaki K, Stridsberg M, Hanson J. The use of Chromogranin A epitopes vasostatin and catestatin as biomarkers for catecholamine-producing tumors in dogs. ESVE-O-5. Malta; 2017. https:\/\/doi.org\/10.1111\/jvim.14858","DOI":"10.1111\/jvim.14858"},{"key":"5996_CR91","doi-asserted-by":"publisher","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. BMC Vet Res. 2020;16(1). https:\/\/doi.org\/10.1186\/s12917-020-02451-y.","DOI":"10.1186\/s12917-020-02451-y"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-026-05996-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-026-05996-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-026-05996-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:03:21Z","timestamp":1792422201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-026-05996-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5996"],"URL":"https:\/\/doi.org\/10.1186\/s12917-026-05996-6","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is reported in agreement with the ARRIVE guidelines [\n                      \n                      ].The study was approved by Ethical committee of Department of Veterinary Medicine, College of Bioresource Sciences, Nihon University, Japan, 2008-04-01, ethical approval number 2801, and an informed consent was obtained from all dog owners.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N.A.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"614"}}